No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SYK240816C340000
- 11.25
- +0.25+2.27%
15min DelayTrading Jul 22 14:31 ET
12.06High10.64Low
11.90Open11.00Pre Close174 Volume296 Open Interest340.00Strike Price193.06KTurnover27.87%IV2.79%PremiumAug 16, 2024Expiry Date1.72Intrinsic Value100Multiplier25DDays to Expiry9.53Extrinsic Value100Contract SizeAmericanOptions Type0.5650Delta0.0157Gamma29.71Leverage Ratio-0.2228Theta0.1263Rho16.79Eff Leverage0.3550Vega
Intraday
- 5D
- Daily
News
Intuitive Surgical's Shares Soared 9.34% After Earnings Release: Unveiling the Competitive Advantages of the Medical Robot Star
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $527 million, or $1.46 per diluted share, compared with $421 million, or $1.18 per diluted share, in the second quarter of 2023.
CereVasc Announces Appointments of New Directors
Medical Device Leaders Shlomi Nachman and Timothy Scannell to join Board of DirectorsBOSTON, July 16, 2024 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel
Stryker Is Maintained at Buy by BTIG
Stryker Is Maintained at Buy by
Express News | Stryker Corporation : Morgan Stanley Raises Target Price to $350.00 From $345.00
Morgan Stanley Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $350
Morgan Stanley analyst Drew Ranieri maintains $Stryker Corp(SYK.US)$ with a hold rating, and adjusts the target price from $345 to $350.According to TipRanks data, the analyst has a success rate of 39
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $372
BTIG analyst Ryan Zimmerman maintains $Stryker Corp(SYK.US)$ with a buy rating, and adjusts the target price from $369 to $372.According to TipRanks data, the analyst has a success rate of 46.6% and
Comments
The stock price of $Intuitive Surgical(ISRG.US$ , the maker of Da Vinci surgical robot system surged 9.34% after its earnings report on Friday, and its market value exceeded $160 billion.
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $52...
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $52...
+1
22
1
The recent insider sale of Stryker shares at the current price is viewed negatively. However, high insider ownership is seen positively, suggesting management's consideration for shareholders. Yet, the absence of insider buying over the past year is worrisome.
The EPS decline doesn't align with share price changes, indicating other factors. Management might be prioritizing revenue growth over EPS. The company's recent performance improvement suggests potential business momentum.
Read more
105535782 : ok